TY - JOUR AU - Becker hr, M. A. AU - Schumacher, H. R. AU - Espinoza, L. R. AU - Wells, A. F. AU - Macdonald, P. AU - Lloyd, E. AU - Lademacher, C. PY - 2010 DA - 2010// TI - The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial JO - Arthritis Res Ther VL - 12 UR - https://doi.org/10.1186/ar2978 DO - 10.1186/ar2978 ID - Becker hr2010 ER - TY - JOUR AU - Becker, M. A. AU - Schumacher, H. R. AU - MacDonald, P. A. AU - Lloyd, E. AU - Lademacher, C. PY - 2009 DA - 2009// TI - Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout JO - J Rheumatol VL - 36 UR - https://doi.org/10.3899/jrheum.080814 DO - 10.3899/jrheum.080814 ID - Becker2009 ER - TY - JOUR AU - Schumacher, H. R. AU - Becker, M. A. AU - Lloyd, E. AU - MacDonald, P. A. AU - Lademacher, C. PY - 2009 DA - 2009// TI - Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study JO - Rheumatology (Oxford) VL - 48 UR - https://doi.org/10.1093/rheumatology/ken457 DO - 10.1093/rheumatology/ken457 ID - Schumacher2009 ER - TY - JOUR AU - Shoji, A. AU - Yamanaka, H. AU - Kamatani, N. PY - 2004 DA - 2004// TI - A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy JO - Arthritis Rheum VL - 51 UR - https://doi.org/10.1002/art.20405 DO - 10.1002/art.20405 ID - Shoji2004 ER - TY - JOUR AU - Becker, M. A. AU - Schumacher, H. R. AU - Wortmann, R. L. AU - MacDonald, P. A. AU - Eustace, D. AU - Palo, W. A. AU - Streit, J. AU - Joseph-Ridge, N. PY - 2005 DA - 2005// TI - Febuxostat compared with allopurinol in patients with hyperuricemia and gout JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa050373 DO - 10.1056/NEJMoa050373 ID - Becker2005 ER - TY - JOUR AU - Becker, M. A. AU - Schumacher, H. R. AU - Wortmann, R. L. AU - MacDonald, P. A. AU - Palo, W. A. AU - Eustace, D. AU - Vernillet, L. AU - Joseph-Ridge, N. PY - 2005 DA - 2005// TI - Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.20935 DO - 10.1002/art.20935 ID - Becker2005 ER - TY - JOUR AU - Schumacher, H. R. AU - Becker, M. A. AU - Wortmann, R. L. AU - Macdonald, P. A. AU - Hunt, B. AU - Streit, J. AU - Lademacher, C. AU - Joseph-Ridge, N. PY - 2008 DA - 2008// TI - Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial JO - Arthritis Rheum VL - 59 UR - https://doi.org/10.1002/art.24209 DO - 10.1002/art.24209 ID - Schumacher2008 ER - TY - JOUR AU - Perez-Ruiz, F. AU - Alonso-Ruiz, A. AU - Calabozo, M. AU - Herrero-Beites, A. AU - Garcia-Erauskin, G. AU - Ruiz-Lucea, E. PY - 1998 DA - 1998// TI - Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout JO - Ann Rheum Dis VL - 57 UR - https://doi.org/10.1136/ard.57.9.545 DO - 10.1136/ard.57.9.545 ID - Perez-Ruiz1998 ER - TY - JOUR AU - Sarawate, C. A. AU - Brewer, K. K. AU - Yang, W. AU - Patel, P. A. AU - Schumacher, H. R. AU - Saag, K. G. AU - Bakst, A. W. PY - 2006 DA - 2006// TI - Gout medication treatment patterns and adherence to standards of care from a managed care perspective JO - Mayo Clin Proc VL - 81 UR - https://doi.org/10.4065/81.7.925 DO - 10.4065/81.7.925 ID - Sarawate2006 ER - TY - JOUR AU - Singh, J. A. AU - Hodges, J. S. AU - Asch, S. M. PY - 2009 DA - 2009// TI - Opportunities for improving medication use and monitoring in gout JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.092619 DO - 10.1136/ard.2008.092619 ID - Singh2009 ER - TY - JOUR AU - Johnson, R. J. AU - Kang, D. H. AU - Feig, D. AU - Kivlighn, S. AU - Kanellis, J. AU - Watanabe, S. AU - Tuttle, K. R. AU - Rodriguez-Iturbe, B. AU - Herrera-Acosta, J. AU - Mazzali, M. PY - 2003 DA - 2003// TI - Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? JO - Hypertension VL - 41 UR - https://doi.org/10.1161/01.HYP.0000069700.62727.C5 DO - 10.1161/01.HYP.0000069700.62727.C5 ID - Johnson2003 ER - TY - JOUR AU - Krishnan, E. AU - Svendsen, K. AU - Neaton, J. D. AU - Grandits, G. AU - Kuller, L. H. PY - 2008 DA - 2008// TI - Long-term cardiovascular mortality among middle-aged men with gout JO - Arch Intern Med VL - 168 UR - https://doi.org/10.1001/archinte.168.10.1104 DO - 10.1001/archinte.168.10.1104 ID - Krishnan2008 ER - TY - JOUR AU - Krishnan, E. AU - Baker, J. F. AU - Furst, D. E. AU - Schumacher, H. R. PY - 2006 DA - 2006// TI - Gout and the risk of acute myocardial infarction JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.22014 DO - 10.1002/art.22014 ID - Krishnan2006 ER - TY - JOUR AU - Voko, Z. AU - Bots, M. L. AU - Hofman, A. AU - Koudstaal, P. J. AU - Witteman, J. C. AU - Breteler, M. M. PY - 1999 DA - 1999// TI - J-shaped relation between blood pressure and stroke in treated hypertensives JO - Hypertension VL - 34 UR - https://doi.org/10.1161/01.HYP.34.6.1181 DO - 10.1161/01.HYP.34.6.1181 ID - Voko1999 ER - TY - JOUR AU - Denardo, S. J. AU - Anderson, R. D. AU - Pepine, C. J. PY - 2008 DA - 2008// TI - Blood pressure targets after high-risk myocardial infarction: is it time to update the guidelines? JO - Hypertension VL - 51 UR - https://doi.org/10.1161/HYPERTENSIONAHA.107.099291 DO - 10.1161/HYPERTENSIONAHA.107.099291 ID - Denardo2008 ER -